DIA会员及用户请点击登录

登录

忘记用户 ID? or 忘记密码?

Not a Member?

创建账户并加入。

Virtual Event

2020 年 06 月 14 日 1:30 下午 - 2020 年 06 月 14 日 5:00 下午

(US Eastern Standard Time)

Fort Washington, PA 19034

#33: R&D QA Comprehensive Quality Strategy: An Approach to Managing Quality Risks Throughout the Drug Development Lifecycle

Instructors

Victoria  Burk

Victoria Burk

Senior Director R&D Quality Assurance, AbbVie, Inc., United States

Vicki Burk is the Sr. Director R&D Quality Assurance Clinical QA Program Management, Combination Products and Medical Devices and the Comprehensive Quality Strategy at AbbVie. She leads teams responsible for Clinical QA across all stages of development and Combination Product/Medical Device Design Quality Assurance. Vicki is also the business process owner for the R&D Comprehensive Quality Strategy, a cross-GxP framework used to manage Quality Risks Throughout the Development Life Cycle. Vicki has held several positions at AbbVie in a broad range of quality, technical and operations disciplines.

Tim  Grey

Tim Grey

Senior Director,R&D Quality Systems, AbbVie, Inc., United States

Tim Grey joined AbbVie in December 2013. He is currently Senior Director of Research and Development Quality Assurance leading the Quality Systems and Support Services team which includes Quality Systems, Documentation Management, training, QKM, QRM, CAPA, Qualification and Validation activities. Tim has spent his career developing, applying, and implementing quality systems principles across the GxP product development lifecycle. Before joining AbbVie, he was with Eli Lilly and Company in various Quality Assurance positions, including the role of a Lean Six Sigma Black Belt. Early in in his career he had the opportunity to work in the Aerospace industry at Rolls Royce Aerospace where he developed his passion for quality.

获得信息并保持参与

不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。